Sex-Specific Survival Bias and Interaction Modeling in Coronary Artery Disease Risk Prediction
暂无分享,去创建一个
Laurent F. Thomas | M. Inouye | C. Willer | I. Surakka | W. Hornsby | K. Hveem | A. H. Skogholt | B. Wolford | L. Thomas | N. Sutton | S. Ritchie | Maiken Elvenstad Gabrielsen | A. Skogholt
[1] J. Danesh,et al. Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses , 2021, PLoS medicine.
[2] Yan V. Sun,et al. Sexual Differences in Genetic Predisposition of Coronary Artery Disease. , 2020, Circulation. Genomic and precision medicine.
[3] Theresa M. Beckie,et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. , 2020, Circulation.
[4] Chiadi E. Ndumele,et al. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index , 2020, JAMA network open.
[5] Eun Sug Park,et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[6] M. Nöthen,et al. Risk prediction for coronary heart disease by a genetic risk score - results from the Heinz Nixdorf Recall study , 2020, BMC medical genetics.
[7] G. McVean,et al. The impact of age on genetic risk for common diseases , 2021, PLoS genetics.
[8] D. Grobbee,et al. Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya , 2020, International journal of cardiology. Heart & vasculature.
[9] Audrey Y. Chu,et al. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers , 2020, Nature Medicine.
[10] P. Elliott,et al. Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. , 2020, JAMA.
[11] Benjamin Neale,et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention , 2019 .
[12] Daniel E Forman,et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.
[13] L. Hooft,et al. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis , 2019, BMC Medicine.
[14] Alicia R. Martin,et al. Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.
[15] J. Shaw,et al. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study , 2019, The Medical journal of Australia.
[16] E. Boersma,et al. Cardiovascular risk prediction models for women in the general population: A systematic review , 2019, PloS one.
[17] Mary E. Haas,et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.
[18] G. Abecasis,et al. Improving power of association tests using multiple sets of imputed genotypes from distributed reference panels , 2017, Genetic epidemiology.
[19] A. Khera,et al. Genetics of coronary artery disease: discovery, biology and clinical translation , 2017, Nature Reviews Genetics.
[20] Markus Perola,et al. Genomic prediction of coronary heart disease , 2016, bioRxiv.
[21] J. Catanese,et al. Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history , 2015, European heart journal.
[22] Olle Melander,et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials , 2015, The Lancet.
[23] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[24] T. Wadden,et al. Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. , 2014, Journal of the American Pharmacists Association : JAPhA.
[25] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[26] K. Hveem,et al. COHORT PROFILE Cohort Profile : The HUNT Study , Norway , 2013 .
[27] John P A Ioannidis,et al. Comparisons of established risk prediction models for cardiovascular disease: systematic review , 2012, BMJ : British Medical Journal.
[28] Carol Coupland,et al. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database , 2010, BMJ : British Medical Journal.
[29] G. Boysen,et al. European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.
[30] I. Njølstad,et al. [Model for estimation of cardiovascular risk in Norway]. , 2008, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[31] K. Anderson,et al. An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.